arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

KALA BIO, Inc.

KALA

$0.74 ▲ +0.01 (+1.23%) at close

12 Visible periods

27 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, KALA BIO, Inc. shows weak fundamentals, weighed down by Return on Invested Capital and Interest Coverage. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $6.0M

Dividend Yield —

Revenue Growth None

Op. Margin —

ROIC -442.2% ↘

FCF / Share $-3.93 ↗

Trailing P/E —

Price / Book 3.0x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

12-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-26.98M

↑ +29.9% —

FCF / Share Free cash flow per share

$-3.93

↑ +49.3% —

Long-Term Debt Long-term obligations

$29.28M

↓ -14.3% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Invested CapitalReturn on Invested Capital of -442.2% is weak on an absolute basis (target > 10%)
Interest CoverageInterest Coverage of -14.50x is weak on an absolute basis (target > 5x)

Health Breakdown

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗
Revenue Growth YoY (%)	—	—	N/M	-65.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-917%)	76.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+858%)	4.7% Caution Caution Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-41%)	—	—	—	N/M	—	—
EPS Growth YoY (%)	67.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	41.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	41.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	72.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-8.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—
Net Income Growth YoY (%)	29.9% Excellent ↑ Excellent Improving Year-over-year change in net income	8.7% Fair ↓ Fair Declining Year-over-year change in net income	5.9% Fair ↓ Fair Declining Year-over-year change in net income	68.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-36.7% Weak → Weak Stable Year-over-year change in net income	-10.6% Weak ↑ Weak Improving Year-over-year change in net income	-41.4% Weak ↑ Weak Improving Year-over-year change in net income	-58.1% Weak ↑ Weak Improving Year-over-year change in net income	-27.3% Weak Weak Year-over-year change in net income	-98.8% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	49.3% Excellent → Excellent Stable Year-over-year change in free cash flow	32.6% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	77.9% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	36.9% Excellent Excellent Year-over-year change in free cash flow	5.0% Fair Fair Year-over-year change in free cash flow	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	-13.8% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	—	—	—	—	—	169.2% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗
FCF / Net Income (x)	1.19x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.66x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.76x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗
Return on Invested Capital (%)	-442.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-77.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-75.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-103.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-106.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-44.1% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-69.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-28.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	32.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	22.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-412.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-73.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-70.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-94.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-93.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-43.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-57.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-29.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-34.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-70.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	—	—	—	-236.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1675%)	—	-104.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-796%)	—	-63.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-524%)	-47.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-414%)	37.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+152%)	29.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+96%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗
Debt to Equity (x)	—	2.37x Weak ↓ Weak Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+296%)	4.56x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+659%)	2.28x Weak ↓ Weak Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+280%)	4.76x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+693%)	0.72x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+20%)	2.40x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+300%)	0.71x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+19%)	0.21x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-65%)	-0.10x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-117%)	—	—
Interest Coverage (x)	-14.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-8.89x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6.82x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-11.24x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-15.54x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-11.20x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-10.40x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-19.53x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-39.13x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-42.59x Weak Weak Operating income divided by interest expense Optimal: > 5x	-26.40x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-7.56M	$-21.90M	$-16.70M	$-27.19M	$-12.14M	$-5.02M	$-14.27M	$75.00M	$18.89M	$9.10M	—	—
Debt / EBITDA (x)	—	-0.72x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.87x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.53x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.62x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.76x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.81x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.17x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.48x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.28x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗
Revenue per Share (USD)	$0.00	$0.00	$0.00	$2.56	$8.54	$6.07	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-3.31	$-10.15	$-17.35	$-29.48	$-108.32	$-99.50	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-3.93	$-7.74	$-11.48	$-51.89	$-82.21	$-86.58	—	—	—	—	—	—
Book Value per Share (USD)	$0.25	$2.02	$2.72	$11.12	$12.71	$84.86	$41.14	$155.00	$182.73	$-3.71K	—	—
Tangible Book Value per Share (USD)	$0.25	$2.02	$2.72	$11.12	$12.71	$84.86	$41.14	$155.00	$182.73	$-3.71K	—	—
Basic Weighted Avg Shares (shares)	8.15M	3.80M	2.43M	1.52M	1.32M	1.05M	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗
Working Capital (USD)	$7.00M	$35.84M	$44.52M	$60.26M	$86.94M	$149.15M	$80.71M	$160.02M	$100.75M	$40.08M	—	—
LT Debt (USD)	—	$29.28M	$34.19M	$43.30M	$80.00M	$72.24M	$71.18M	$75.00M	$18.89M	$9.10M	—	—
Total Equity (USD)	$7.00M	$12.33M	$7.50M	$18.97M	$16.80M	$100.00M	$29.69M	$104.98M	$89.68M	$-87.76M	$-56.66M	$-40.72M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗
Sales/Revenue/Turnover (USD)	$0.00	$0.00	$0.00	$3.89M	$11.24M	$6.36M	$6.07M	—	$0.00	$0.00	$45.00K	—
Depreciation Expense (USD)	$317.00K	$259.00K	$303.00K	$537.00K	$975.00K	$912.00K	$843.00K	$352.00K	$287.00K	$297.00K	$330.00K	—
Net Income, GAAP (USD)	$-26.98M	$-38.51M	$-42.20M	$-44.82M	$-142.60M	$-104.33M	$-94.35M	$-66.74M	$-42.21M	$-33.17M	$-16.68M	—
Operating Cash Flow (USD)	$-31.99M	$-29.38M	$-27.93M	$-78.91M	$-108.23M	$-90.69M	$-92.72M	$-54.12M	$-34.10M	$-27.35M	$-15.09M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 12 years · 42 quarters

KALA BIO, Inc.

Analytical Summary

12-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare KALA with peers